Chronic obstructive pulmonary disease in non-smokers: A case-comparison study

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 11, Issue 1, 2014, Pages 2-9

  Sexton, Paul ^a   Black, Peter ^a   Wu, Lian ^a   Sommerville, Fay ^a   Hamed, Maye ^b   Milne, David ^b   Metcalf, Patricia ^a   Kolbe, John ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Asthma; Bronchiectasis; Chronic Obstructive Pulmonary Disease; High resolution computed tomography; Nonsmoker

Indexed keywords

ALLERGEN; NITRIC OXIDE;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; EMPHYSEMA; EOSINOPHIL COUNT; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INFLAMMATION; INTERVIEW; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTPATIENT DEPARTMENT; PHLEBOTOMY; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SKIN TEST; SMOKING; SPIROMETRY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ASTHMA; BREATH TESTS; BRONCHIECTASIS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; EOSINOPHILIA; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; NITRIC OXIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SKIN TESTS; SMOKING; SPIROMETRY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84893249903     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2013.800853     Document Type: Article

References (66)

1. World Health Organization. World Health Statistics 2011. WHO Press, Geneva, 2011.
2. National Heart Lung and Blood Institute. Morbidity and Mortalitity: Chart Book on Cardiovascular, Lung, and Blood Diseases: National Heart, Lung and Blood Institute; 2009.
3. Lamprecht B, McBurnie MA, Vollmer WM, Gudmundsson G, Welte T, Nizankowska-Mogilnicka E, Studnicka M, Bateman E, Anto JM, Burney P, Mannino DM, Buist SA, the BOLD Collaborative Research Group f. COPD in Never Smokers: Results From the Population-Based Burden of Obstructive Lung Disease Study. Chest 2011; 139(4):752-763.
4. Coultas DB, Mapel D, Gagnon R, Lydick E. Th e health impact of undiagnosed airfl ow obstruction in a national sample of United States adults. Am J Respir Crit Care Med 2001; 164(3):372-377.
5. Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez- Padilla R, Postma D, Romieu I, Silverman EK, Balmes JR, Committee on Nonsmoking COPD E, Assembly OH. An offi cial American Th oracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 182(5):693-718.
6. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD. 2013; Available from: http://www.goldcopd.org/.
7. Love RG, Miller BG. Longitudinal study of lung function in coal-miners. Thorax 1982; 37(3):193-197.
8. Balmes J, Becklake M, Blanc P, Henneberger P, Kreiss K, Mapp C, Milton D, Schwartz D, Toren K, Viegi G. American Th oracic Society Statement: Occupational contribution to the burden of airway disease. Am J Respir Crit Care Med 2003; 167(5):787-797.
9. Smith KR. Inaugural article: national burden of disease in India from indoor air pollution. Proc Natl Acad Sci USA 2000; 97(24):13286-13293.
10. Lieberman J, Winter B, Sastre A. Alpha 1-antitrypsin Pi-types in 965 COPD patients. Chest 1986; 89(3):370-373.
11. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339(17):1194-1200.
12. Ulrik CS, Backer V. Nonreversible airfl ow obstruction in lifelong nonsmokers with moderate to severe asthma. Eur Respir J 1999; 14(4):892-896.
13. Silva GE, Sherrill DL, Guerra S, Barbee RA. Asthma as a risk factor for COPD in a longitudinal study. Chest 2004; 126(1):59-65.
14. Eder W, Ege MJ, von Mutius E. Th e asthma epidemic. N Engl J Med 2006; 355(21):2226-2235.
15. James AL, Palmer LJ, Kicic E, Maxwell PS, Lagan SE, Ryan GF, Musk AW. Decline in lung function in the Busselton Health Study: the eff ects of asthma and cigarette smoking. Am J Respir Crit Care Med 2005; 171(2):109-114.
16. Dijkstra A, Vonk JM, Jongepier H, Koppelman GH, Schouten JP, ten Hacken NHT, Timens W, Postma DS. Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex. Thorax 2006; 61(2):105-110.
17. Ulrik CS, Lange P. Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med 1994; 150(3):629-634.
18. de Marco R, Accordini S, Marcon A, Cerveri I, Antó JM, Gislason T, Heinrich J, Janson C, Jarvis D, Kuenzli N, Leynaert B, Sunyer J, Svanes C, Wjst M, Burney P, the European Community Respiratory Health Survey (ECRHS) f. Risk Factors for Chronic Obstructive Pulmonary Disease in a European Cohort of Young Adults. Am J Respir Crit Care Med 2011; 183:891-897.
19. Foreman MG, Zhang L, Murphy J, Hansel NN, Make B, Hokanson JE, Washko G, Regan EA, Crapo JD, Silverman EK, DeMeo DL, Investigators COPDG. Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study. Am J Respir Crit Care Med 2011; 184(4):414-420.
20. Hardin M, Silverman EK, Barr RG, Hansel NN, Schroeder JD, Make BJ, Crapo JD, Hersh CP, Investigators tC. Th e clinical features of the overlap between COPD and asthma. Respir Res 2011; 12(1):127.
21. Rijcken B, Schouten JP, Xu X, Rosner B, Weiss ST. Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1. Am J Respir Crit Care Med 1995: 151(5): 1377-1382.
22. Brown PJ, Greville HW, Finucane KE. Asthma and irreversible airfl ow obstruction. Thorax 1984; 39(2):131-136.
23. Finucane KE, Greville HW, Brown PJ. Irreversible airfl ow obstruction. Evolution in asthma. Med J Aust 1985; 142(11):602-604.
24. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Respir J 2005; 26(2):319-338.
25. Roberts HR, Wells AU, Milne DG, Rubens MB, Kolbe J, Cole PJ, Hansell DM. Airfl ow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests. Thorax 2000; 55(3):198-204.
26. Bhalla M, Turcios N, Aponte V, Jenkins M, Leitman BS, McCauley DI, Naidich DP. Cystic fi brosis: scoring system with thin-section CT. Radiology 1991; 179(3):783-788.
27. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. Eur Respir J 2005; 26(5):948-968.
28. Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. Th e signifi cance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 1959; 2(5147):257-266.
29. Sung A, Naidich D, Belinskaya I, Raoof S. Th e role of chest radiography and computed tomography in the diagnosis and management of asthma. Curr Opin Pulm Med 2007; 13(1):31-36.
30. Lee JH, Haselkorn T, Borish L, Rasouliyan L, Chipps BE, Wenzel SE. Risk factors associated with persistent airfl ow limitation in severe or diffi cult-to-treat asthma: insights from the TENOR study. Chest 2007; 132(6):1882-1889.
31. Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, Ligabue G, Ciaccia A, Saetta M, Papi A. Diff erences in airway infl ammation in patients with fi xed airfl ow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167(3):418-424.
32. Jeff ery PK. Comparison of the structural and infl ammatory features of COPD and asthma. Giles F. Filley Lecture. Chest 2000; 117(5 Suppl 1):251S-260S.
33. Larj MJ, Bleecker ER. Therapeutic responses in asthma and COPD. Corticosteroids. Chest 2004; 126(2 Suppl):138S-149S; discussion 159S-161S.
34. Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, Chu HW. Evidence that severe asthma can be divided pathologically into two infl ammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999; 160(3):1001-1008.
35. Ulrik CS, Backer V, Dirksen A. A 10 year follow up of 180 adults with bronchial asthma: factors important for the decline in lung function. Thorax 1992; 47(1):14-18.
36. Shaw DE, Berry MA, Hargadon B, McKenna S, Shelley MJ, Green RH, Brightling CE, Wardlaw AJ, Pavord ID. Association between neutrophilic airway infl ammation and airfl ow limitation in adults with asthma. Chest 2007; 132(6):1871-1875.
37. Kharitonov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996; 153(1):454-457.
38. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O'Byrne P, Pedersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31(1):143-178.
39. Brand PL, Quanjer PH, Postma DS, Kerstjens HA, Koëter GH, Dekhuijzen PN, Sluiter HJ. Interpretation of bronchodilator response in patients with obstructive airways disease. Th e Dutch Chronic Non-Specifi c Lung Disease (CNSLD) Study Group. Thorax 1992; 47(6):429-436.
40. Calverley PMA, Burge PS, Spencer S, Anderson JA, Jones PW. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003; 58(8):659-664.
41. Schermer T, Heijdra Y, Zadel S, van den Bemt L, Winter LB-d, Dekhuijzen R, Smeele I. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD. Respir Med 2007; 101(6):1355-1362.
42. Braman SS, Kaemmerlen JT, Davis SM. Asthma in the elderly. A comparison between patients with recently acquired and longstanding disease. Am Rev Respir Dis 1991; 143(2):336-340.
43. Cassino C, Berger KI, Goldring RM, Norman RG, Kammerman S, Ciotoli C, Reibman J. Duration of asthma and physiologic outcomes in elderly nonsmokers. Am J Respir Crit Care Med 2000; 162(4 Pt 1):1423-1428.
44. Connolly CK, Chan NS, Prescott RJ. Th e relationship between age and duration of asthma and the presence of persistent obstruction in asthma. Postgrad Med J 1988; 64(752):422-425.
45. Rasmussen F, Taylor DR, Flannery EM, Cowan JO, Greene JM, Herbison GP, Sears MR. Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/vital capacity ratio: a longitudinal population study from childhood to adulthood. Am J Respir Crit Care Med 2002; 165(11): 1480-1488.
46. Tennant PWG, Gibson GJ, Pearce MS. Lifecourse predictors of adult respiratory function: results from the Newcastle Th ousand Families Study. Thorax 2008; 63(9):823-830.
47. Morgan WJ, Stern DA, Sherrill DL, Guerra S, Holberg CJ, Guilbert TW, Taussig LM, Wright AL, Martinez FD. Outcome of asthma and wheezing in the fi rst 6 years of life: follow-up through adolescence. Am J Respir Crit Care Med 2005; 172(10):1253-1258.
48. Tai ASN, Tran H, Roberts M, Clarke N, Wilson JW, Robertson CF. Pediatric origins of adult chronic obstructive pulmonary disease (COPD): Childhood asthma. Am J Respir Crit Care Med 2010; 181:A2275.
49. O'Byrne PM, Pedersen S, Busse WW, Tan WC, Chen Y-Z, Ohlsson SV, Ullman A, Lamm CJ, Pauwels RA, Group STARTI. Eff ects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma. Chest 2006; 129(6):1478-1485.
50. Zhou Y, Wang C, Yao W, Chen P, Kang J, Huang S, Chen B, Ni D, Wang X, Wang D, Liu S, Lu J, Zheng J, Zhong N, Ran P. COPD in Chinese nonsmokers. Eur Respir J 2009; 33(3):509-518.
51. Barker DJ, Godfrey KM, Fall C, Osmond C, Winter PD, Shaheen SO. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ 1991; 303(6804):671-675.
52. Reed CE. Th e natural history of asthma in adults: the problem of irreversibility. J Allergy Clin Immunol 1999; 103(4):539-547.
53. Boulet LP, Turcotte H, Hudon C, Carrier G, Maltais F. Clinical, physiological and radiological features of asthma with incomplete reversibility of airfl ow obstruction compared with those of COPD. Can Respir J 1998; 5(4): 270-277.
54. Biernacki W, Redpath AT, Best JJ, MacNee W. Measurement of CT lung density in patients with chronic asthma. Eur Respir J 1997; 10(11):2455-2459.
55. Vignola AM, Paganin F, Capieu L, Scichilone N, Bellia M, Maakel L, Bellia V, Godard P, Bousquet J, Chanez P. Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD. Eur Respir J 2004; 24(6):910-917.
56. Yilmaz S, Ekici A, Ekici M, Keles H. High-resolution computed tomography fi ndings in elderly patients with asthma. Eur J Radiol 2006; 59(2):238-243.
57. Patel IS, Vlahos I, Wilkinson TMA, Lloyd-Owen SJ, Donaldson GC, Wilks M, Reznek RH, Wedzicha JA. Bronchiectasis, exacerbation indices, and infl ammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170(4):400-407.
58. Bafadhel M, Umar I, Gupta S, Raj JV, Vara DD, Entwisle JJ, Pavord ID, Brightling CE, Siddiqui S. Th e role of CT scanning in multidimensional phenotyping of COPD. Chest 2011; 140(3):634-642.
59. O'Brien C, Guest PJ, Hill SL, Stockley RA. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax 2011; 183:891-897.
60. Paganin F, Seneterre E, Chanez P, Daures JP, Bruel JM, Michel FB, Bousquet J. Computed tomography of the lungs in asthma: infl uence of disease severity and etiology. Am J Respir Crit Care Med 1996; 153(1):110-114.
61. Bisaccioni C, Aun MV, Cajuela E, Kalil J, Agondi RC, Giavina- Bianchi P. Comorbidities in severe asthma: frequency of rhinitis, nasal polyposis, gastroesophageal refl ux disease, vocal cord dysfunction and bronchiectasis. Clinics (Sao Paulo) 2009; 64(8):769-773.
62. Gupta S, Siddiqui S, Haldar P, Raj JV, Entwisle JJ, Wardlaw AJ, Bradding P, Pavord ID, Green RH, Brightling CE. Qualitative analysis of high-resolution CT scans in severe asthma. Chest 2009; 136(6):1521-1528.
63. Grenier P, Mourey-Gerosa I, Benali K, Brauner MW, Leung AN, Lenoir S, Cordeau MP, Mazoyer B. Abnormalities of the airways and lung parenchyma in asthmatics: CT observations in 50 patients and inter- and intraobserver variability. Eur Radiol 1996; 6(2):199-206.
64. Izquierdo JL, Martin A, de Lucas P, Rodriguez-Gonzalez- Moro JM, Almonacid C, Paravisini A. Misdiagnosis of patients receiving inhaled therapies in primary care. Int J Chron Obstruct Pulmon Dis 2010: 5:241-249.
65. Marklund B, Tunsater A, Bengtsson C. How often is the diagnosis bronchial asthma correct? Fam Pract 1999; 16(2):112-116.
66. Abramson MJ, Schattner RL, Sulaiman ND, Colle EAD, Aroni R, Th ien F. Accuracy of asthma and COPD diagnosis in Australian general practice: a mixed methods study. Prim Care Respir J 2012; 21:167-173.